440 related articles for article (PubMed ID: 20149605)
21. Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.
Yang L; Bataller R; Dulyx J; Coffman TM; Ginès P; Rippe RA; Brenner DA
J Hepatol; 2005 Aug; 43(2):317-23. PubMed ID: 15964094
[TBL] [Abstract][Full Text] [Related]
22. Glucocorticoid pretreatment suppresses chemokine expression and inflammatory cell infiltration in cholestatic rats receiving biliary intervention.
Hsieh CS; Wang PW; Lee SY; Huang CC; Chang NK; Chen CM; Wu CL; Wang HC; Chuang JH
J Pediatr Surg; 2006 Oct; 41(10):1669-75. PubMed ID: 17011266
[TBL] [Abstract][Full Text] [Related]
23. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment.
Ramm GA; Shepherd RW; Hoskins AC; Greco SA; Ney AD; Pereira TN; Bridle KR; Doecke JD; Meikle PJ; Turlin B; Lewindon PJ
Hepatology; 2009 Feb; 49(2):533-44. PubMed ID: 19115220
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
25. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
[TBL] [Abstract][Full Text] [Related]
26. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis.
Uchinami H; Seki E; Brenner DA; D'Armiento J
Hepatology; 2006 Aug; 44(2):420-9. PubMed ID: 16871591
[TBL] [Abstract][Full Text] [Related]
27. Activation of necroptosis in human and experimental cholestasis.
Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
[TBL] [Abstract][Full Text] [Related]
28. Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.
Abdel-Aziz G; Lebeau G; Rescan PY; Clément B; Rissel M; Deugnier Y; Campion JP; Guillouzo A
Am J Pathol; 1990 Dec; 137(6):1333-42. PubMed ID: 2260623
[TBL] [Abstract][Full Text] [Related]
29. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
[TBL] [Abstract][Full Text] [Related]
30. Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes.
Oh SH; Yun KJ; Nan JX; Sohn DH; Lee BH
Arch Toxicol; 2003 Feb; 77(2):110-5. PubMed ID: 12590363
[TBL] [Abstract][Full Text] [Related]
31. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury.
Hines JE; Johnson SJ; Burt AD
Am J Pathol; 1993 Feb; 142(2):511-8. PubMed ID: 8434646
[TBL] [Abstract][Full Text] [Related]
32. Nicotinamide induces apoptosis and reduces collagen I and pro-inflammatory cytokines expression in rat hepatic stellate cells.
Traister A; Breitman I; Bar-Lev E; Zvibel I; Harel A; Halpern Z; Oren R
Scand J Gastroenterol; 2005 Oct; 40(10):1226-34. PubMed ID: 16165703
[TBL] [Abstract][Full Text] [Related]
33. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
34. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
35. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow cell transplantation is associated with fibrogenic cells apoptosis during hepatic regeneration in cholestatic rats.
Nunes de Carvalho S; da Cunha Lira D; Costa Cortez EA; de Andrade DC; Thole AA; Stumbo AC; de Carvalho L
Biochem Cell Biol; 2013 Apr; 91(2):88-94. PubMed ID: 23527637
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
38. The effect of ischemia on the regeneration of the cholestatic liver. An experimental study.
Karavias D; Tsamandas AC; Tepetes K; Kritikos N; Kourelis T; Mirra N; Bonikos DS; Androulakis J
Hepatogastroenterology; 2002; 49(44):456-60. PubMed ID: 11995473
[TBL] [Abstract][Full Text] [Related]
39. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis.
Canbay A; Higuchi H; Bronk SF; Taniai M; Sebo TJ; Gores GJ
Gastroenterology; 2002 Oct; 123(4):1323-30. PubMed ID: 12360492
[TBL] [Abstract][Full Text] [Related]
40. Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice.
Takemura T; Yoshida Y; Kiso S; Kizu T; Furuta K; Ezaki H; Hamano M; Egawa M; Chatani N; Kamada Y; Imai Y; Higashiyama S; Iwamoto R; Mekada E; Takehara T
Biochem Biophys Res Commun; 2013 Jul; 437(2):185-91. PubMed ID: 23743191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
